Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy

Photonics and Lasers in Medicine

Volumn 2, Issue 4, 2013, Pages 287-303

  Rollakanti, Kishore R ^a,b   Kanick, Stephen C ^c   Davis, Scott C ^c   Pogue, Brian W ^c   Maytin, Edward V ^a,b  

^a Cleveland State University   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c DARTMOUTH COLLEGE   (United States)

Author keywords

Fluorescence; Photodynamic therapy; Protoporphyrin IX; Treatment planning

Indexed keywords

FLUORESCENCE; HISTOLOGY; OPTICAL TOMOGRAPHY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS;

FLUORESCENCE DETECTION; FLUORESCENCE DETECTION TECHNIQUES; FLUORESCENT MEASUREMENTS; MICROSCOPIC TECHNIQUES; MULTI-MODAL TECHNIQUES; PHOTODYNAMIC THERAPY (PDT); PROTOPORPHYRIN IX; TREATMENT PLANNING;

TISSUE;

AMINOLEVULINIC ACID; COBALT; FERROUS ION; FLUOROCHROME; HEME; LIQUID NITROGEN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; VITAMIN D;

ACTINIC KERATOSIS; AUTOFLUORESCENCE; BASAL CELL CARCINOMA; BIOSYNTHESIS; BLEACHING; CAMERA; CANCER THERAPY; CONFOCAL LASER MICROSCOPY; DOSIMETER; DRUG DELIVERY SYSTEM; FIBER OPTICS; FLUORESCENCE; FLUORESCENCE LIFETIME IMAGING MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN CELL; HUMAN TISSUE; ILLUMINATION; IMAGE QUALITY; IMAGE RECONSTRUCTION; IMAGING SYSTEM; INFRARED RADIATION; LASER; LIGHT ABSORPTION; LUMINESCENCE; MICROSCOPY; MOLECULAR IMAGING; MOLECULAR PROBE; MULTIPHOTON TOMOGRAPHY; NON INVASIVE MEASUREMENT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PHOTON; PHOTOSENSITIZATION; REVIEW; SKIN CANCER; SKIN LYMPHOMA; SKIN TUMOR; SOLID TUMOR; SPECTROFLUOROMETRY; SPECTROMETER; STRUCTURED ILLUMINATION MICROSCCOPY; T CELL LYMPHOMA; TOMOGRAPHY; TREATMENT PLANNING; TREATMENT RESPONSE; ULTRASOUND;

EID: 84893780822     PISSN: 21930635     EISSN: 21930643     Source Type: Journal    
DOI: 10.1515/plm-2013-0030     Document Type: Review

References (113)

1. Hasan T, Ortel B, Solban N, Pogue B. Photodynamic therapy of cancer. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock R, Weichselbaum RR, Gansler T, Holland JF, Frei E III, editors. Cancer Medicine. 7th ed. Hamilton (Ontario, Canada): BC Decker, Inc.; 2006. p. 537-48.
2. Goldman L, editor. The biomedical laser. New York: Springer- Verlag; 1981.
3. Katzir A. Lasers and optical fibers in medicine. San Diego: Academic Press; 1993.
4. Raab O. Über die Wirkung fluorescierender Stoffe auf Infusoria. Z Biol 1900;39:524-46.
5. MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyrins Phathalocyanines 2001;5(2):105-29. (Pubitemid 32125231)
6. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985;45(4):1608-10. (Pubitemid 15079112)
7. Henderson BW, Miller AC. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res 1986;108(2):196-205. (Pubitemid 17207553)
8. Foote CS. Mechanisms of photooxygenation. Prog Clin Biol Res 1984;170:3-18.
9. Halkiotis K, Yova D, Pantelias G. In vitro evaluation of the genotoxic and clastogenic potential of photodynamic therapy. Mutagenesis 1999;14(2):193-8. (Pubitemid 29123784)
10. MacCormack MA. Photodynamic therapy. Adv Dermatol 2006;22:219-58. (Pubitemid 44960616)
11. Campbell SM, Tyrrell J, Marshall R, Curnow A. Effect of MAL-photodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn Ther 2010;7(3):183-8.
12. Dunn JM, Mackenzie GD, Banks MR, Mosse CA, Haidry R, Green S, Thorpe S, Rodriguez-Justo M, Winstanley A, Novelli MR, Bown SG, Lovat LB. A randomised controlled trial of ALA vs. photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus. Lasers Med Sci 2013;28(3):707-15.
13. Juzeniene A, Peng Q, Moan J. Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem Photobiol Sci 2007;6(12):1234-45. (Pubitemid 350191101)
14. Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett 2012;326(1):8-16.
15. Berlin NI, Neuberger A, Scott JJ. The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N. Biochem J 1956;64(1):80-90.
16. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992;14(4):275-92.
17. Valentine RM, Ibbotson SH, Wood K, Brown CT. Modelling fluorescence in clinical photodynamic therapy. Photochem Photobiol Sci 2013;12(1):203-13.
18. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci 1997;12(3):182-99. (Pubitemid 27404122)
19. Patterson MS, Wilson BC, Graff R. In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem Photobiol 1990;51(3):343-9.
20. Niedre M, Patterson MS, Wilson BC. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem Photobiol 2002;75(4):382-91.
21. Jarvi MT, Niedre MJ, Patterson MS, Wilson BC. Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects. Photochem Photobiol 2006;82(5):1198-210. (Pubitemid 44701998)
22. Lee S, Vu DH, Hinds MF, Davis SJ, Liang A, Hasan T. Pulsed diode laser-based singlet oxygen monitor for photodynamic therapy: in vivo studies of tumor-laden rats. J Biomed Opt 2008;13(6):064035.
23. Gemmell NR, McCarthy A, Liu B, Tanner MG, Dorenbos SD, Zwiller V, Patterson MS, Buller GS, Wilson BC, Hadfield RH. Singlet oxygen luminescence detection with a fiber-coupled superconducting nanowire single-photon detector. Opt Express 2013;21(4):5005-13.
24. Wilson BC, Patterson MS. The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 2008;53(9):R61-109.
25. Nadeau V, O'Dwyer M, Hamdan K, Tait I, Padgett M. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities. Photodermatol Photoimmunol Photomed 2004;20(4):170-4. (Pubitemid 39077012)
26. Moan J, Ma L, Iani V, Juzeniene A. Influence of light exposure on the kinetics of protoporphyrin IX formation in normal skin of hairless mice after application of 5-aminolevulinic acid methyl ester. J Invest Dermatol 2005;125(5):1039-44.
27. Juzenas P, Juzeniene A. Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors. Photodiagnosis Photodyn Ther 2010;7(3):152-7.
28. Wagnières GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 1998;68(5):603-32. (Pubitemid 128472287)
29. Bodaness RS, Heller DF, Krasinski J, King DS. The two-photon laser-induced fluorescence of the tumor-localizing photosensitizer hematoporphyrin derivative. Resonance-enhanced 750 nm two-photon excitation into the near-UV Soret band. J Biol Chem 1986;261(26):12098-101. (Pubitemid 17202768)
30. Burke TG, Malak H, Gryczynski I, Mi Z, Lakowicz JR. Fluorescence detection of the anticancer drug topotecan in plasma and whole blood by two-photon excitation. Anal Biochem 1996;242(2):266-70. (Pubitemid 26386824)
31. Wu J, Feld MS, Rava RP. Analytical model for extracting intrinsic fluorescence in turbid media. Appl Opt 1993;32(19): 3585-95.
32. Ahmed SA, Zang ZW, Yoo KM, Ali MA, Alfano RR. Effect of multiple light scattering and self-absorption on the fluorescence and excitation spectra of dyes in random media. Appl Opt 1994;33(13):2746-50.
33. Durkin AJ, Jaikumar S, Ramanujam N, Richards-Kortum R. Relation between fluorescence spectra of dilute and turbid samples. Appl Opt 1994;33(3):414-23.
34. Bradley RS, Thorniley MS. A review of attenuation correction techniques for tissue fluorescence. J R Soc Interface 2006;3(6):1-13. (Pubitemid 46682200)
35. Gruber JD, Paliwal A, Krishnaswamy V, Ghadyani H, Jermyn M, O'Hara JA, Davis SC, Kerley-Hamilton JS, Shworak NW, Maytin EV, Hasan T, Pogue BW. System development for high frequency ultrasound-guided fluorescence quantification of skin layers. J Biomed Opt 2010;15(2):026028.
36. Kim A, Khurana M, Moriyama Y, Wilson BC. Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements. J Biomed Opt 2010;15(6):067006.
37. Bigio IJ, Mourant JR. Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elasticscattering spectroscopy. Phys Med Biol 1997;42(5):803-14. (Pubitemid 27263501)
38. Lim L, Nichols B, Rajaram N, Tunnell JW. Probe pressure effects on human skin diffuse reflectance and fluorescence spectroscopy measurements. J Biomed Opt 2011;16(1):011012.
39. de Leeuw J, van der Beek N, Neugebauer WD, Bjerring P, Neumann HA. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage. Lasers Surg Med 2009;41(2):96-103.
40. Wang I, Svanberg K, Andersson-Engels S, Berg R, Svanberg S. Photodynamic therapy of non-melanoma skin malignancies with topical δ-amino levulinic acid: diagnostic measurements. Proc SPIE 1995;2371:243-52.
41. Johansson J, Berg R, Svanberg K, Svanberg S. Laser-induced fluorescence studies of normal and malignant tumour tissue of rat following intravenous injection of delta-amino levulinic acid. Lasers Surg Med 1997;20(3):272-9. (Pubitemid 27200205)
42. Peng Q, Moan J, Warloe T, Nesland JM, Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 1992;52(3):433-43.
43. Rhodes LE, Tsoukas MM, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997;108(1):87-91. (Pubitemid 27019851)
44. Lesar A, Padgett M, O'Dwyer M, Ferguson J, Moseley H. Fluorescence induced by aminolevulinic acid and methyl aminolevulinate on normal skin. Photodiagnosis Photodyn Ther 2007;4(4):224-9. (Pubitemid 350152069)
45. Dögnitz N, Salomon D, Zellweger M, Ballini JP, Gabrecht T, Lange N, van den Bergh H, Wagnières G. Comparison of ALAand ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. J Photochem Photobiol B 2008;93(3):140-8.
46. Di Venosa G, Hermida L, Fukuda H, Defain MV, Rodriguez L, Mamone L, MacRobert A, Casas A, Batlle A. Comparation of liposomal formulations of ALA undecanoyl ester for its use in photodynamic therapy. J Photochem Photobiol B 2009;96(2):152-8.
47. Bender J, Ericson MB, Merclin N, Iani V, Rosén A, Engström S, Moan J. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release 2005;106(3):350-60. (Pubitemid 41187444)
48. Donnelly RF, Juzenas P, McCarron PA, Ma LW, Woolfson AD, Moan J. Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo. Photodiagnosis Photodyn Ther 2006;3(3):190-201. (Pubitemid 46137925)
49. Golub AL, Dickson EFG, Kennedy JC, Marcus SL, Park Y, Pottier RH. The monitoring of ALA-induced protoporphyrin IX accumulation and clearance in patients with skin lesions by in vivo surface-detected fluorescence spectroscopy. Laser Med Sci 1999;14(2):112-22. (Pubitemid 29338647)
50. Warren CB, Lohser S, Wene LC, Pogue BW, Bailin PL, Maytin EV. Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate. J Biomed Opt 2010;15(5):051607.
51. Ascencio M, Collinet P, Farine MO, Mordon S. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg Med 2008;40(5):332-41. (Pubitemid 351920383)
52. Heyerdahl H, Wang I, Liu DL, Berg R, Andersson-Engels S, Peng Q, Moan J, Svanberg S, Svanberg K. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues. Cancer Lett 1997;112(2):225-31. (Pubitemid 27104299)
53. Pye A, Curnow A. Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells. Photochem Photobiol 2007;83(3):766-73. (Pubitemid 46854964)
54. Profio AE, Doiron DR, King EG. Laser fluorescence bronchoscope for localization of occult lung tumors. Med Phys 1979;6(6):523-5. (Pubitemid 10185597)
55. Straight RC, Benner RE, McClane RW, Go PM, Yoon G, Dixon JA. Application of charge-coupled device technology for measurement of laser light and fluorescence distribution in tumors for photodynamic therapy. Photochem Photobiol 1991;53(6):787-96.
56. Tyrrell J, Campbell SM, Curnow A. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Photodiagnosis Photodyn Ther 2011;8(1):30-8.
57. van der Beek N, de Leeuw J, Demmendal C, Bjerring P, Neumann HA. PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alone in fluorescence detection of non-melanoma skin cancer: an intra-patient direct comparison study. Lasers Surg Med 2012;44(4):271-6.
58. Baumgartner R, Fisslinger H, Jocham D, Lenz H, Ruprecht L, Stepp H, Unsöld E. A fluorescence imaging device for endoscopic detection of early stage cancer-instrumental and experimental studies. Photochem Photobiol 1987;46(5):759-63.
59. Brodbeck KJ, Profio AE, Frewin T, Balchum OJ. A system for real time fluorescence imaging in color for tumor diagnosis. Med Phys 1987;14(4):637-9. (Pubitemid 18012516)
60. Kohl M, Neukammer J, Sukowski U, Rinneberg HH, Sinn HJ, Friedrich EA, Graschew G, Schlag PM, Woehrle D. Imaging of tumors by time-delayed laser-induced fluorescence. Proc SPIE 1991;1525:26-34. doi:10.1117/12.48208.
61. Andersson-Engels S, Johansson J, Svanberg K, Svanberg S. Multi-colour fluorescence imaging in connection with photodynamic therapy of deltaaminolevulinic acid (ALA) sensitised skin malignancies. Bioimaging 1995;3:134-43. (Pubitemid 26080607)
62. Fischer F, Dickson EF, Pottier RH, Wieland H. An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part I. Design, spectral and spatial characteristics. Lasers Med Sci 2001;16(3):199-206. (Pubitemid 32606450)
63. Hewett J, Nadeau V, Ferguson J, Moseley H, Ibbotson S, Allen JW, Sibbett W, Padgett M. The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers. Photochem Photobiol 2001;73(3):278-82.
64. Cuccia DJ, Bevilacqua F, Durkin AJ, Ayers FR, Tromberg BJ. Quantitation and mapping of tissue optical properties using modulated imaging. J Biomed Opt 2009;14(2):024012.
65. Saager RB, Cuccia DJ, Saggese S, Kelly KM, Durkin AJ. Quantitative fluorescence imaging of protoporphyrin IX through determination of tissue optical properties in the spatial frequency domain. J Biomed Opt 2011;16(12):126013.
66. Sunar U, Rohrbach DJ, Morgan J, Zeitouni N, Henderson BW. Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging. Biomed Opt Express 2013;4(4):531-7.
67. Valdes PA, Leblond F, Kim A, Wilson BC, Paulsen KD, Roberts DW. A spectrally constrained dual-band normalization technique for protoporphyrin IX quantification in fluorescenceguided surgery. Opt Lett 2012;37(11):1817-9.
68. Lue N, Kang JW, Yu CC, Barman I, Dingari NC, Feld MS, Dasari RR, Fitzmaurice M. Portable optical fiber probe-based spectroscopic scanner for rapid cancer diagnosis: a new tool for intraoperative margin assessment. PLoS One 2012;7(1):e30887.
69. Rossberger S, Ach T, Best G, Cremer C, Heintzmann R, Dithmar S. High-resolution imaging of autofluorescent particles within drusen using structured illumination microscopy. Br J Ophthalmol 2013;97(4):518-23.
70. Hoffman ZR, DiMarzio CA. Structured illumination microscopy using random intensity incoherent reflectance. J Biomed Opt 2013;18(6):061216.
71. Ducros N, Bassi A, Valentini G, Canti G, Arridge S, D'Andrea C. Fluorescence molecular tomography of an animal model using structured light rotating view acquisition. J Biomed Opt 2013;18(2):20503.
72. Zhu Q, Chen NG, Piao D, Guo P, Ding X. Design of near-infrared imaging probe with the assistance of ultrasound localization. Appl Opt 2001;40(19):3288-303.
73. Cammarota T, Pinto F, Magliaro A, Sarno A. Current uses of diagnostic high-frequency US in dermatology. Eur J Radiol 1998;27(Suppl 2):S215-23. (Pubitemid 28270598)
74. Flynn BP, D'Souza AV, Kanick SC, Davis SC, Pogue BW. White light-informed optical properties improve ultrasound-guided fluorescence tomography of photoactive protoporphyrin IX. J Biomed Opt 2013;18(4):046008.
75. Desai TD, Desai AD, Horowitz DC, Kartono F, Wahl T. The use of high-frequency ultrasound in the evaluation of superficial and nodular basal cell carcinomas. Dermatol Surg 2007;33(10):1220-7; discussion 1226-7.
76. Crisan M, Crisan D, Sannino G, Lupsor M, Badea R, Amzica F. Ultrasonographic staging of cutaneous malignant tumors: an ultrasonographic depth index. Arch Dermatol Res 2013;305(4):305-13.
77. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, Fujimoto JG. Optical coherence tomography. Science 1991;254(5035): 1178-81. (Pubitemid 21917444)
78. Gambichler T, Orlikov A, Vasa R, Moussa G, Hoffmann K, Stucker M, Altmeyer P, Bechara FG. In vivo optical coherence tomography of basal cell carcinoma. J Dermatol Sci 2007;45(3):167-73. (Pubitemid 46216048)
79. Mogensen M, Nurnberg BM, Forman JL, Thomsen JB, Thrane L, Jemec GB. In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound. Br J Dermatol 2009;160(5):1026-33.
80. Yun S, Tearney G, Bouma B, Park B, de Boer J. High-speed spectral-domain optical coherence tomography at 1.3 mum wavelength. Opt Express 2003;11(26):3598-604.
81. Kepshire DS, Davis SC, Dehghani H, Paulsen KD, Pogue BW. Subsurface diffuse optical tomography can localize absorber and fluorescent objects but recovered image sensitivity is nonlinear with depth. Appl Opt 2007;46(10):1669-78. (Pubitemid 46659533)
82. Kepshire D, Davis SC, Dehghani H, Paulsen KD, Pogue BW. Fluorescence tomography characterization for sub-surface imaging with protoporphyrin IX. Opt Express 2008;16(12):8581-93.
83. Davis SC, Dehghani H, Wang J, Jiang S, Pogue BW, Paulsen KD. Image-guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization. Opt Express 2007;15(7):4066-82. (Pubitemid 46557568)
84. Boone MA, Norrenberg S, Jemec GB, Del Marmol V. Imaging of basal cell carcinoma by high-definition optical coherence tomography: histomorphological correlation. A pilot study. Br J Dermatol 2012;167(4):856-64.
85. Maier T, Braun-Falco M, Hinz T, Schmid-Wendtner MH, Ruzicka T, Berking C. Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology. J Eur Acad Dermatol Venereol 2013;27(1):e97-104.
86. Selkin B, Rajadhyaksha M, Gonzalez S, Langley RG. In vivo confocal microscopy in dermatology. Dermatol Clin 2001;19(2):369-77, ix-x. (Pubitemid 32807774)
87. Chung VQ, Dwyer PJ, Nehal KS, Rajadhyaksha M, Menaker GM, Charles C, Jiang SB. Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers. Dermatol Surg 2004;30(12 Pt 1):1470-8. (Pubitemid 40053556)
88. Lademann J, Otberg N, Richter H, Meyer L, Audring H, Teichmann A, Thomas S, Knuttel A, Sterry W. Application of optical non-invasive methods in skin physiology: a comparison of laser scanning microscopy and optical coherent tomography with histological analysis. Skin Res Technol 2007;13(2):119-32. (Pubitemid 46443675)
89. Astner S, Dietterle S, Otberg N, Rowert-Huber HJ, Stockfleth E, Lademann J. Clinical applicability of in vivo fluorescence confocal microscopy for noninvasive diagnosis and therapeutic monitoring of nonmelanoma skin cancer. J Biomed Opt 2008;13(1):014003.
90. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, Bentley MV. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release 2000;65(3):359-66. (Pubitemid 30122938)
91. Masters BR, So PT, Gratton E. Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. Biophys J 1997;72(6):2405-12. (Pubitemid 27227578)
92. König K, Riemann I. High-resolution multiphoton tomography of human skin with subcellular spatial resolution and picosecond time resolution. J Biomed Opt 2003;8(3):432-9.
93. Schenke-Layland K, Riemann I, Damour O, Stock UA, König K. Two-photon microscopes and in vivo multiphoton tomographs - powerful diagnostic tools for tissue engineering and drug delivery. Adv Drug Deliv Rev 2006;58(7):878-96. (Pubitemid 44794345)
94. Lin SJ, Jee SH, Dong CY. Multiphoton microscopy: a new paradigm in dermatological imaging. Eur J Dermatol 2007;17(5):361-6.
95. Becker W, Bergmann A, Biskup C. Multispectral fluorescence lifetime imaging by TCSPC. Microsc Res Tech 2007;70(5):403-9. (Pubitemid 46786937)
96. Elson D, Requejo-Isidro J, Munro I, Reavell F, Siegel J, Suhling K, Tadrous P, Benninger R, Lanigan P, McGinty J, Talbot C, Treanor B, Webb S, Sandison A, Wallace A, Davis D, Lever J, Neil M, Phillips D, Stamp G, French P. Time-domain fluorescence lifetime imaging applied to biological tissue. Photochem Photobiol Sci 2004;3(8):795-801. (Pubitemid 39302981)
97. Benati E, Bellini V, Borsari S, Dunsby C, Ferrari C, French P, Guanti M, Guardoli D, Koenig K, Pellacani G, Ponti G, Schianchi S, Talbot C, Seidenari S. Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopy. Skin Res Technol 2011. doi: 10.1111/j.1600-0846.2011.00496.x.
98. Seidenari S, Arginelli F, Dunsby C, French P, König K, Magnoni C, Manfredini M, Talbot C, Ponti G. Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics. Exp Dermatol 2012;21(11):831-6.
99. Madsen SJ, Sun CH, Tromberg BJ, Wallace VP, Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid. Photochem Photobiol 2000;72(1): 128-34.
100. Lu S, Chen JY, Zhang Y, Ma J, Wang PN, Peng Q. Fluorescence detection of protoporphyrin IX in living cells: a comparative study on single- and two-photon excitation. J Biomed Opt 2008;13(2):024014.
101. Goyan RL, Cramb DT. Near-infrared two-photon excitation of protoporphyrin IX: photodynamics and photoproduct generation. Photochem Photobiol 2000;72(6):821-7.
102. Riemann I, Ehlers A, Dill-Müller D, Martin S, König K. Multiphoton tomography of skin tumors after ALA application. Proc SPIE 2007;6424:642405. doi:10.1117/12.702411. (Pubitemid 47319161)
103. Cicchi R, Sestini S, De Giorgi V, Massi D, Lotti T, Pavone FS. Nonlinear laser imaging of skin lesions. J Biophotonics 2008;1(1):62-73.
104. Kantelhardt SR, Diddens H, Leppert J, Rohde V, Hüttmann G, Giese A. Multiphoton excitation fluorescence microscopy of 5-aminolevulinic acid induced fluorescence in experimental gliomas. Lasers Surg Med 2008;40(4):273-81. (Pubitemid 351628530)
105. Kemmner W, Wan K, Rüttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 2008;22(2):500-9. (Pubitemid 351225586)
106. Kantere D, Guldbrand S, Paoli J, Goksör M, Hanstorp D, Wennberg AM, Smedh M, Ericson MB. Anti-stokes fluorescence from endogenously formed protoporphyrin IX - implications for clinical multiphoton diagnostics. J Biophotonics 2013;6(5):409-15.
107. Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006;155(6):1262-9. (Pubitemid 44730005)
108. Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Haedersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2laser: a randomized clinical trial. Br J Dermatol 2012;166(6): 1262-9.
109. Tyrrell JS, Campbell SM, Curnow A. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 2010;42(7):613-9.
110. de Bruijn HS, Meijers C, van der Ploeg-van den Heuvel A, Sterenborg HJ, Robinson DJ. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate. J Photochem Photobiol B 2008;92(2):91-7.
111. de Haas ER, Kruijt B, Sterenborg HJ, Martino Neumann HA, Robinson DJ. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol 2006;126(12):2679-86. (Pubitemid 44764052)
112. de Haas ER, de Bruijn HS, Sterenborg HJ, Neumann HA, Robinson DJ. Microscopic distribution of protoporphyrin (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 2008;88(6):547-54.
113. de Vijlder HC, Sterenborg HJ, Neumann HA, Robinson DJ, de Haas ER. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. Acta Derm Venereol 2012;92(6):641-7.